vs
MERIT MEDICAL SYSTEMS INC（MMSI）与Revolve Group, Inc.（RVLV）财务数据对比。点击上方公司名可切换其他公司
MERIT MEDICAL SYSTEMS INC的季度营收约是Revolve Group, Inc.的1.2倍（$393.9M vs $324.4M），MERIT MEDICAL SYSTEMS INC净利率更高（9.6% vs 5.7%，领先3.9%），MERIT MEDICAL SYSTEMS INC同比增速更快（10.9% vs 10.4%），MERIT MEDICAL SYSTEMS INC自由现金流更多（$74.0M vs $-13.3M），过去两年MERIT MEDICAL SYSTEMS INC的营收复合增速更高（10.3% vs 9.5%）
梅里特医疗系统公司是一家全球性医疗设备企业，设计、生产和销售适用于心脏病学、放射学、肿瘤学、内窥镜及重症监护领域的介入和诊断产品，为全球医院及医疗机构提供微创医疗解决方案，助力提升患者疗效和临床操作效率。
Revolve Theatre Company是总部位于英国泰晤士河畔亨利的剧团，专注于创作演出政治题材和莎士比亚系列戏剧作品，由奥利弗·登奇、乔·莫里斯与汤姆·史密斯共同创立运营。
MMSI vs RVLV — 直观对比
营收规模更大
MMSI
是对方的1.2倍
$324.4M
营收增速更快
MMSI
高出0.5%
10.4%
净利率更高
MMSI
高出3.9%
5.7%
自由现金流更多
MMSI
多$87.3M
$-13.3M
两年增速更快
MMSI
近两年复合增速
9.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $393.9M | $324.4M |
| 净利润 | $38.0M | $18.6M |
| 毛利率 | 49.6% | 53.3% |
| 营业利润率 | 13.8% | 6.3% |
| 净利率 | 9.6% | 5.7% |
| 营收同比 | 10.9% | 10.4% |
| 净利润同比 | 36.0% | 50.4% |
| 每股收益（稀释后） | $0.64 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MMSIRVLV
| Q4 25 | $393.9M | $324.4M | ||
| Q3 25 | $384.2M | $295.6M | ||
| Q2 25 | $382.5M | $309.0M | ||
| Q1 25 | $355.4M | $296.7M | ||
| Q4 24 | $355.2M | $293.7M | ||
| Q3 24 | $339.8M | $283.1M | ||
| Q2 24 | $338.0M | $282.5M | ||
| Q1 24 | $323.5M | $270.6M |
净利润MMSIRVLV
| Q4 25 | $38.0M | $18.6M | ||
| Q3 25 | $27.8M | $21.2M | ||
| Q2 25 | $32.6M | $10.2M | ||
| Q1 25 | $30.1M | $11.8M | ||
| Q4 24 | $27.9M | $12.3M | ||
| Q3 24 | $28.4M | $11.0M | ||
| Q2 24 | $35.7M | $15.4M | ||
| Q1 24 | $28.2M | $10.9M |
毛利率MMSIRVLV
| Q4 25 | 49.6% | 53.3% | ||
| Q3 25 | 48.5% | 54.6% | ||
| Q2 25 | 48.2% | 54.1% | ||
| Q1 25 | 48.4% | 52.0% | ||
| Q4 24 | 48.7% | 52.5% | ||
| Q3 24 | 46.4% | 51.2% | ||
| Q2 24 | 47.7% | 54.0% | ||
| Q1 24 | 46.9% | 52.3% |
营业利润率MMSIRVLV
| Q4 25 | 13.8% | 6.3% | ||
| Q3 25 | 11.1% | 7.1% | ||
| Q2 25 | 12.3% | 5.8% | ||
| Q1 25 | 11.5% | 5.0% | ||
| Q4 24 | 10.3% | 3.9% | ||
| Q3 24 | 11.0% | 5.0% | ||
| Q2 24 | 13.6% | 5.8% | ||
| Q1 24 | 11.1% | 3.4% |
净利率MMSIRVLV
| Q4 25 | 9.6% | 5.7% | ||
| Q3 25 | 7.2% | 7.2% | ||
| Q2 25 | 8.5% | 3.3% | ||
| Q1 25 | 8.5% | 4.0% | ||
| Q4 24 | 7.9% | 4.2% | ||
| Q3 24 | 8.4% | 3.9% | ||
| Q2 24 | 10.6% | 5.4% | ||
| Q1 24 | 8.7% | 4.0% |
每股收益（稀释后）MMSIRVLV
| Q4 25 | $0.64 | $0.27 | ||
| Q3 25 | $0.46 | $0.29 | ||
| Q2 25 | $0.54 | $0.14 | ||
| Q1 25 | $0.49 | $0.16 | ||
| Q4 24 | $0.46 | $0.18 | ||
| Q3 24 | $0.48 | $0.15 | ||
| Q2 24 | $0.61 | $0.21 | ||
| Q1 24 | $0.48 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $446.4M | $292.3M |
| 总债务越低越好 | $734.0M | — |
| 股东权益账面价值 | $1.6B | $512.5M |
| 总资产 | $2.7B | $765.0M |
| 负债/权益比越低杠杆越低 | 0.46× | — |
8季度趋势，按日历期对齐
现金及短期投资MMSIRVLV
| Q4 25 | $446.4M | $292.3M | ||
| Q3 25 | $392.5M | $315.4M | ||
| Q2 25 | $341.8M | $310.7M | ||
| Q1 25 | $395.5M | $300.8M | ||
| Q4 24 | $376.7M | $256.6M | ||
| Q3 24 | $523.1M | $252.8M | ||
| Q2 24 | $636.7M | $244.7M | ||
| Q1 24 | $581.9M | $273.4M |
总债务MMSIRVLV
| Q4 25 | $734.0M | — | ||
| Q3 25 | $732.9M | — | ||
| Q2 25 | $731.8M | — | ||
| Q1 25 | $730.7M | — | ||
| Q4 24 | $729.6M | — | ||
| Q3 24 | $750.5M | — | ||
| Q2 24 | $801.3M | — | ||
| Q1 24 | $800.1M | — |
股东权益MMSIRVLV
| Q4 25 | $1.6B | $512.5M | ||
| Q3 25 | $1.5B | $490.2M | ||
| Q2 25 | $1.5B | $468.6M | ||
| Q1 25 | $1.4B | $453.4M | ||
| Q4 24 | $1.4B | $437.8M | ||
| Q3 24 | $1.3B | $420.8M | ||
| Q2 24 | $1.3B | $405.8M | ||
| Q1 24 | $1.2B | $389.9M |
总资产MMSIRVLV
| Q4 25 | $2.7B | $765.0M | ||
| Q3 25 | $2.6B | $751.3M | ||
| Q2 25 | $2.6B | $722.9M | ||
| Q1 25 | $2.5B | $713.9M | ||
| Q4 24 | $2.4B | $665.5M | ||
| Q3 24 | $2.4B | $670.9M | ||
| Q2 24 | $2.4B | $657.8M | ||
| Q1 24 | $2.3B | $650.0M |
负债/权益比MMSIRVLV
| Q4 25 | 0.46× | — | ||
| Q3 25 | 0.48× | — | ||
| Q2 25 | 0.49× | — | ||
| Q1 25 | 0.51× | — | ||
| Q4 24 | 0.53× | — | ||
| Q3 24 | 0.57× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.65× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $98.5M | $-10.2M |
| 自由现金流经营现金流 - 资本支出 | $74.0M | $-13.3M |
| 自由现金流率自由现金流/营收 | 18.8% | -4.1% |
| 资本支出强度资本支出/营收 | 6.2% | 1.0% |
| 现金转化率经营现金流/净利润 | 2.59× | -0.55× |
| 过去12个月自由现金流最近4个季度 | $215.7M | $48.0M |
8季度趋势，按日历期对齐
经营现金流MMSIRVLV
| Q4 25 | $98.5M | $-10.2M | ||
| Q3 25 | $75.0M | $11.8M | ||
| Q2 25 | $83.3M | $12.6M | ||
| Q1 25 | $40.6M | $45.1M | ||
| Q4 24 | $68.7M | $3.9M | ||
| Q3 24 | $47.3M | $9.1M | ||
| Q2 24 | $68.5M | $-24.7M | ||
| Q1 24 | $36.2M | $38.4M |
自由现金流MMSIRVLV
| Q4 25 | $74.0M | $-13.3M | ||
| Q3 25 | $52.5M | $7.5M | ||
| Q2 25 | $69.6M | $10.4M | ||
| Q1 25 | $19.5M | $43.4M | ||
| Q4 24 | $65.3M | $2.1M | ||
| Q3 24 | $38.0M | $8.0M | ||
| Q2 24 | $57.9M | $-25.7M | ||
| Q1 24 | $24.5M | $36.7M |
自由现金流率MMSIRVLV
| Q4 25 | 18.8% | -4.1% | ||
| Q3 25 | 13.7% | 2.5% | ||
| Q2 25 | 18.2% | 3.4% | ||
| Q1 25 | 5.5% | 14.6% | ||
| Q4 24 | 18.4% | 0.7% | ||
| Q3 24 | 11.2% | 2.8% | ||
| Q2 24 | 17.1% | -9.1% | ||
| Q1 24 | 7.6% | 13.5% |
资本支出强度MMSIRVLV
| Q4 25 | 6.2% | 1.0% | ||
| Q3 25 | 5.8% | 1.5% | ||
| Q2 25 | 3.6% | 0.7% | ||
| Q1 25 | 5.9% | 0.6% | ||
| Q4 24 | 1.0% | 0.6% | ||
| Q3 24 | 2.8% | 0.4% | ||
| Q2 24 | 3.1% | 0.4% | ||
| Q1 24 | 3.6% | 0.6% |
现金转化率MMSIRVLV
| Q4 25 | 2.59× | -0.55× | ||
| Q3 25 | 2.70× | 0.56× | ||
| Q2 25 | 2.56× | 1.24× | ||
| Q1 25 | 1.35× | 3.82× | ||
| Q4 24 | 2.46× | 0.32× | ||
| Q3 24 | 1.66× | 0.83× | ||
| Q2 24 | 1.92× | -1.60× | ||
| Q1 24 | 1.28× | 3.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MMSI
| Other | $154.6M | 39% |
| Peripheral Intervention | $93.2M | 24% |
| Cardiac Intervention | $50.2M | 13% |
| OEM | $42.6M | 11% |
| Custom Procedural Solutions | $33.1M | 8% |
| Endoscopy Segment | $20.1M | 5% |
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
